(Q73143101)
Statements
An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group (English)
K Sugimachi
Y Maehara
N Horikoshi
Y Shimada
Y Sakata
Y Mitachi